Blinding
Blinding (Medical Term)
Blinding (pronunciation: /ˈblʌɪndɪŋ/) is a method used in clinical trials to prevent bias by not letting the participants, the person administering the treatment, or the person evaluating the research know who is receiving a particular treatment. This method is used to prevent any preconceived notions or bias from affecting the results of the trial.
Etymology
The term "blinding" comes from the phrase "to blind" which means to make someone unable to see, in this case, the details of the treatment being administered. This term has been used in the context of clinical trials since the mid-20th century.
Related Terms
- Double-blind: A type of blinding where both the participant and the person administering treatment do not know what treatment is being given. This is done to prevent both parties from being biased.
- Single-blind: A type of blinding where only the participant does not know what treatment they are receiving. This is done to prevent the participant from being biased.
- Triple-blind: A type of blinding where the participant, the person administering treatment, and the person evaluating the results do not know what treatment is being given. This is done to prevent all parties from being biased.
- Bias: A tendency to lean in a certain direction, either in favor of or against a particular thing. In the context of clinical trials, bias can affect the results of the trial.
- Clinical trial: A type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
External links
- Medical encyclopedia article on Blinding
- Wikipedia's article - Blinding
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski